<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03156322</url>
  </required_header>
  <id_info>
    <org_study_id>Inonu Anesthesia</org_study_id>
    <nct_id>NCT03156322</nct_id>
  </id_info>
  <brief_title>Different Epidural Initiation Volumes</brief_title>
  <official_title>Effects of Different Epidural Initiation Volumes on Postoperative Analgesia in Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effect of different epidural initiation volumes on
      postoperative pain scores, local anesthetic requirements, and motor block in patients who
      undergo patient controlled epidural analgesia for postoperative pain after cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      90 minutes after combined epidural spinal catheter insertion, three different volumes (5 mL,
      10 mL, and 20 mL) are administered with a patient-controlled epidural analgesia (PCEA) device
      through the epidural catheter. For each group, 0.625% bupivacain + 2 μg/mL fentanyl, is
      administered.

      The visual analog scale, first analgesic demand time, the number of PCEA requirement per
      hour, morphine requirement, nausea-vomiting, itching, motor block, hypotension, and total
      consumed analgesic, and ephedrine amounts of the patients are recorded in the recovery room
      and at postoperative 2, 4, 6, 12 hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">January 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 1, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in postoperative pain scores</measure>
    <time_frame>up to 12 hours after cesarean delivery</time_frame>
    <description>Visual analog scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First analgesic demand time</measure>
    <time_frame>up to 12 hours after cesarean delivery</time_frame>
    <description>Time to first analgesic requirement (first patient controlled epidural analgesic demand time)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of analgesic requirement</measure>
    <time_frame>up to 12 hours after cesarean delivery</time_frame>
    <description>The number of patient controlled epidural analgesic requirement per hour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine requirement</measure>
    <time_frame>up to 12 hours after cesarean delivery</time_frame>
    <description>Intravenous morphine administration</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Side effects associated with epidural analgesia</measure>
    <time_frame>up to 12 hours after cesarean delivery</time_frame>
    <description>Nausea-vomiting, itching, motor block, hypotension</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">81</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 mL epidural initiation volume (bupivacaine + fentanyl)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 10</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 mL epidural initiation volume (bupivacaine + fentanyl)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 20</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 mL epidural initiation volume (bupivacaine + fentanyl)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5 mL epidural initiation volume (bupivacaine + fentanyl)</intervention_name>
    <description>5 mL 0.625% bupivacaine + 2 μg/mL fentanyl solution is administered from epidural catheter</description>
    <arm_group_label>Group 5</arm_group_label>
    <other_name>Bupivacaine(Marcaine 0.5%), Fentanyl(Talinat 0.5mg/10mL)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10 mL epidural initiation volume (bupivacaine + fentanyl)</intervention_name>
    <description>10 mL 0.625% bupivacaine + 2 μg/mL fentanyl solution is administered from epidural catheter</description>
    <arm_group_label>Group 10</arm_group_label>
    <other_name>Bupivacaine(Marcaine 0.5%), Fentanyl(Talinat 0.5mg/10mL)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>20 mL epidural initiation volume (bupivacaine + fentanyl)</intervention_name>
    <description>20 mL 0.625% bupivacaine + + 2 μg/mL fentanyl solution is administered from epidural catheter</description>
    <arm_group_label>Group 20</arm_group_label>
    <other_name>Bupivacaine(Marcaine 0.5%), Fentanyl(Talinat 0.5mg/10mL)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiology risks classification II

          -  Term pregnant

        Exclusion Criteria:

          -  Multiple pregnancy

          -  Diabetes mellitus

          -  Hypertension

          -  Coagulopathy

          -  Severe cardiac, neurological and pulmonary disease

          -  Allergy to the study drugs

          -  Difficulty in understanding the use of the patient controlled analgesia device
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmut Durmus, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Prof Dr</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inonu University Turgut Ozal Medical Center</name>
      <address>
        <city>Malatya</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Sng BL, Woo D, Leong WL, Wang H, Assam PN, Sia AT. Comparison of computer-integrated patient-controlled epidural analgesia with no initial basal infusion versus moderate basal infusion for labor and delivery: A randomized controlled trial. J Anaesthesiol Clin Pharmacol. 2014 Oct;30(4):496-501. doi: 10.4103/0970-9185.142842.</citation>
    <PMID>25425774</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>May 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2017</study_first_posted>
  <last_update_submitted>May 16, 2017</last_update_submitted>
  <last_update_submitted_qc>May 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Osman Kacmaz</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>combined spinal epidural anesthesia</keyword>
  <keyword>patient controlled epidural analgesia</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

